Aberrant expression of CD6 on B-cell subsets from patients with Sjögren’s syndrome-Reference-Cited by-同舟云学术

Aberrant expression of CD6 on B-cell subsets from patients with Sjögren’s syndrome

Published:2010-12 Issue:4 Volume:35 Page:336-341
ISSN:0896-8411
Container-title:Journal of Autoimmunity
language:en
Short-container-title:Journal of Autoimmunity

Author:

Alonso Ruby,Buors Caroline,Le Dantec Christelle,Hillion Sophie,Pers Jacques-Olivier,Saraux Alain,Montero Enrique,Marianowski Rémi,Loisel Séverine,Devauchelle Valérie,Youinou Pierre,Renaudineau Yves

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference40 articles.

1. Sjögren’s syndrome: autoimmune epithelitis;Moutsopoulos;Clin Immunol Immunopathol,1994

2. Immunohistologic analysis of lymphoid infiltrates in primary Sjögren’s syndrome using monoclonal antibodies;Adamson;J Immunol,1983

3. The weight of interleukin-6 in B cell-related autoimmune disorders;Youinou;J Autoimmun,2009

4. B cell-targeted therapies in Sjögren’s syndrome;Tobón;Autoimmun Rev,2010

5. The point on the ongoing B-cell depleting trials currently in progress over the world in primary Sjögren’s syndrome;Saraux;Autoimmun Rev,2010

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Soluble CD72, is a T-cell activator probably via binding to CD6 in homeostasis and autoimmunity;Frontiers in Immunology;2024-07-04

2. Emerging biologic frontiers for Sjogren’s syndrome: Unveiling novel approaches with emphasis on extra glandular pathology;Frontiers in Pharmacology;2024-05-17

3. The dual role of CD6 as a therapeutic target in cancer and autoimmune disease;Frontiers in Medicine;2022-10-05

4. Gene Variation at Immunomodulatory and Cell Adhesion Molecules Loci Impacts Primary Sjögren's Syndrome;Frontiers in Medicine;2022-03-18

5. The role of serum free light chain as biomarker of Myasthenia Gravis;Clinica Chimica Acta;2022-03